Sleep apnoea syndrome (SAS) is a common sleep disorder with a prevalence ranging from 5.9% to 79.2% in the European general population over 40 years of age, depending on the clinical symptoms and apnoea hypopnoea scoring criteria used [1]. Despite its frequency, the fact that it is a significant risk factor for many common diseases, and a recent meta-analysis demonstrating that available treatments are effective [2], SAS remains underdiagnosed. Mandibular movement tests have demonstrated potential as screening tools for polysomnography candidates <http://ow.ly/iu2430fZk2u> Data were provided by the Brizzy registry (Nomics, Belgium). However, Nomics was in no way involved in this analysis, nor did they provide any kind of incentive to any of the authors.
No takes yet. Share an insight, caveat, or question.
Rotty et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: